BIOTEST AG/ DE0005227201 /
22/06/2023 12:27:18 | Diferencia -0.10 | Volumen | Bid- | Ask- | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
42.60EUR | -0.23% | 26 Volumen de negocios: 1,107.60 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 1.63 mil millonesEUR | 0.10% | - |
GlobeNewswire
10:00
FTI Consulting Appoints UK Head of Capital Markets in the Strategic Communications Segment
GlobeNewswire
10:00
DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with ...
GlobeNewswire
10:00
GL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Globe Life Inc. Investors with S...
GlobeNewswire
10:00
AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Inves...
GlobeNewswire
10:00
DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with ...
GlobeNewswire
10:00
SSRM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SSR Mining Inc. Investors with...
GlobeNewswire
10:00
EXAI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Exscientia p.l.c. Investors wi...
GlobeNewswire
10:00
MBUU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Malibu Boats, Inc. Investors w...
GlobeNewswire
9:05
Advantest Unveils New Ultra-High-Current Power Supply for V93000 EXA Scale SoC Test System
Newsfile Corp
9:00
Gulf Land Property Developers Announces New Luxury Residences in Dubai in Partnership with Tonino La...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página